Monaco TRP System The Monaco system is used to make treatment plans for patients with prescripti...

FDA Device Recall #Z-0668-2017 — Class II — November 17, 2016

Recall Summary

Recall Number Z-0668-2017
Classification Class II — Moderate risk
Date Initiated November 17, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Elekta, Inc.
Location Atlanta, GA
Product Type Devices
Quantity 2148

Product Description

Monaco TRP System The Monaco system is used to make treatment plans for patients with prescriptions for external beam radiation therapy.

Reason for Recall

Contours are not handled correctly if the CT dataset contains slices with DICOM Z coordinates of xx.x50mm.

Distribution Pattern

Worldwide Distribution - US including AK, AZ, CA, CO, FL, GA, IL, IN, KY, LA, MD, MA, MI, MN, MO, MT, NV, NH, NJ, NY, NC, ND, OH, OK, OR, PA, SD, TX, UT, VA, WA, WI, Puerto Rico and Internationally to Algeria, Antiqua & Barbuda, Argentina, Australia, Austria, Bahrain, Belarus, Botswana, Brazil, Bulgaria, Canada, Chile, China, Columbia, Croatia, Cuba, Cyprus, Czech Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Indonesia, Iran, Iraq, Israel, Italy, Japan, Laos, Lithuania, Malaysia, Malta, Mexico, Morocco, Myanmar, Namibia, Nepal, Netherlands, New Zealand, Norway, Panama, Peru, Philippines, Poland, Portugal, Romania, Russia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sri Lanka, Sweden, Switzerland, Thailand, Tunisia, Turkey, Unite Kingdom, Ukraine, Venezuela, Vietnam, and Zimbabwe.

Lot / Code Information

Software Builds 5.00 and higher

Other Recalls from Elekta, Inc.

Recall # Classification Product Date
Z-1581-2026 Class II Brand Name: Leksell Gamma Knife Product Descri... Feb 18, 2026
Z-1164-2026 Class II Brand Name: Elekta Medical Linear Accelerator ... Dec 14, 2025
Z-1339-2026 Class II Brand Name: Leksell GammaPlan Product Name: Ra... Dec 12, 2025
Z-1340-2026 Class II Brand Name: Leksell GammaPlan Product Name: Ra... Dec 12, 2025
Z-1078-2026 Class II MOSAIQ Oncology Information System with Particl... Dec 10, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.